Berthold Langguth Selected Research

Tinnitus

11/2022	Random Forest Classification to Predict Response to High-Definition Transcranial Direct Current Stimulation for Tinnitus Relief: A Preliminary Feasibility Study.
1/2022	Personalization of Repetitive Transcranial Magnetic Stimulation for the Treatment of Chronic Subjective Tinnitus.
1/2022	Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial.
12/2021	Unification of Treatments and Interventions for Tinnitus Patients (UNITI): a study protocol for a multi-center randomized clinical trial.
6/2021	Heading for Personalized rTMS in Tinnitus: Reliability of Individualized Stimulation Protocols in Behavioral and Electrophysiological Responses.
1/2021	Efficacy and safety of single- and repeated-selurampanel dosing for 2 weeks in patients with chronic subjective tinnitus: Results of a randomized, double-blind, placebo-controlled, cross-over, proof-of-concept phase IIa study.
1/2021	Conventional versus notch filter amplification for the treatment of tinnitus in adults with mild-to-moderate hearing loss.
1/2021	Emerging Topics in the Behavioral Neuroscience of Tinnitus.
1/2021	Lidocaine injections to the otic ganglion for the treatment of tinnitus-A pilot study.
1/2021	Vagus nerve stimulation for tinnitus: A review and perspective.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Berthold Langguth Research Topics

Disease

110	Tinnitus 11/2022 - 05/2003
17	Schizophrenia (Dementia Praecox) 01/2022 - 11/2004
5	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 04/2004
5	Epilepsy (Aura) 01/2017 - 05/2011
3	Depressive Disorder (Melancholia) 02/2022 - 01/2019
3	Bipolar Disorder (Manic Depressive Psychosis) 02/2022 - 03/2008
3	Movement Disorders (Movement Disorder) 01/2019 - 11/2014
3	Hypothermia 12/2017 - 02/2012
3	Pain (Aches) 01/2017 - 11/2014
3	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 04/2016 - 11/2014
3	Sleep Deprivation 04/2012 - 10/2007
3	Hallucinations (Hallucination) 02/2008 - 04/2006
2	Major Depressive Disorder (Major Depressive Disorders) 01/2019 - 12/2017
2	Hyperacusis (Phonophobia) 10/2017 - 01/2016
2	Neuralgia (Stump Neuralgia) 01/2017 - 11/2007
2	Multiple Sclerosis 01/2017 - 11/2014
2	Consciousness Disorders 01/2017 - 11/2014
2	Stroke (Strokes) 01/2017 - 11/2014
2	Mood Disorders (Mood Disorder) 09/2014 - 01/2012
1	Dizziness (Lightheadedness) 01/2021
1	Hearing Loss (Hearing Impairment) 01/2021
1	Ganglion Cysts (Ganglion) 01/2021
1	Dystonia (Limb Dystonia) 11/2020
1	Neurodevelopmental Disorders 11/2020
1	Cognitive Dysfunction 03/2020
1	Treatment-Resistant Depressive Disorder 04/2017
1	Fibromyalgia (Fibrositis) 01/2017
1	Aphasia (Dysphasia) 01/2017
1	Parkinson Disease (Parkinson's Disease) 01/2017
1	Headache Disorders (Headache Syndromes) 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 07/2015
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2014
1	Anxiety Disorders (Anxiety Disorder) 11/2014
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2014
1	Seizures (Absence Seizure) 09/2013
1	Alcoholism (Alcohol Abuse) 09/2013
1	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2013
1	Dementia (Dementias) 07/2012

Drug/Important Bio-Agent (IBA)

14	salicylhydroxamic acid (SHAM)IBA 01/2022 - 10/2003
12	Pharmaceutical PreparationsIBA 01/2019 - 04/2004
9	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 12/2006
7	Therapeutic UsesIBA 01/2022 - 01/2012
5	Olanzapine (Zyprexa)FDA Link 01/2022 - 12/2006
4	Antidepressive Agents (Antidepressants)IBA 11/2014 - 10/2007
3	Lidocaine (Xylocaine)FDA LinkGeneric 01/2021 - 01/2019
3	Potassium Channels (Potassium Channel)IBA 01/2016 - 04/2010
3	Quetiapine Fumarate (Seroquel)FDA Link 06/2014 - 03/2008
3	Dopamine (Intropin)FDA LinkGeneric 04/2011 - 11/2004
3	Deoxyglucose (2 Deoxy D glucose)IBA 12/2006 - 05/2003
2	Amisulpride (Solian)IBA 01/2022 - 02/2020
2	EnzymesIBA 11/2020 - 11/2004
2	Indicators and Reagents (Reagents)IBA 10/2017 - 01/2014
2	PlacebosIBA 01/2016 - 04/2005
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2016 - 01/2013
1	selurampanelIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	AMPA Receptors (AMPA Receptor)IBA 01/2021
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2021
1	Excitatory Amino Acid AntagonistsIBA 01/2021
1	purineIBA 11/2020
1	Mineralocorticoid Receptor AntagonistsIBA 03/2020
1	Spironolactone (Aldactone)FDA LinkGeneric 03/2020
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019
1	Clozapine (Clozaril)FDA LinkGeneric 01/2019
1	E 10 (E-10)IBA 01/2019
1	zolmitriptan (Zomig)FDA Link 01/2017
1	Hormones (Hormone)IBA 01/2017
1	Nasal SpraysIBA 01/2017
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2017
1	Asu(1,6)- argipressin (VAS-A)IBA 01/2017
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2017
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2017
1	Analgesics (Analgesic Drugs)IBA 11/2014
1	N 30IBA 06/2014
1	BenperidolIBA 07/2012
1	cyclobenzaprine FDA LinkGeneric 01/2012
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 09/2011

Therapy/Procedure

66	Transcranial Magnetic Stimulation 02/2022 - 10/2003
21	Therapeutics 12/2021 - 04/2006
11	Transcranial Direct Current Stimulation 11/2022 - 07/2008
6	Aftercare (After-Treatment) 10/2020 - 09/2010
5	Drug Therapy (Chemotherapy) 01/2021 - 12/2009
4	Vagus Nerve Stimulation 01/2021 - 01/2012
3	Hearing Aids (Hearing Aid) 12/2021 - 04/2013
2	Duration of Therapy 01/2021 - 01/2019
2	Deep Brain Stimulation 04/2017 - 07/2015
2	Electrodes (Electrode) 01/2015 - 02/2012
2	Implanted Electrodes 07/2008 - 01/2008
1	Injections 01/2021
1	Combined Modality Therapy 01/2018
1	Music Therapy 05/2017
1	Chronotherapy 01/2017
1	Relaxation Therapy (Relaxation Technique) 10/2016
1	Psychosurgery (Lobotomy) 04/2016
1	Neurofeedback 01/2014
1	Contraindications 09/2013
1	Prosthodontics 11/2011
1	Transcutaneous Electric Nerve Stimulation (TENS) 10/2011